80 likes | 142 Views
Get more details @ http://bit.ly/2pya5qn <br>Major industry companies for Protein A Resins Market include GE Healthcare, Repligen, GenScript, Tosoh Bioscience, Merck Millipore (EMD Millipore), Thermo Fisher Scientific, Novasep, Expedeon, Bio-Rad Laboratories, Danaher Corporation, Sigma-Aldrich, Purolite Life Sciences, Takara Bio, and Agarose Bead Technologies.
E N D
Protein A Resins Market to reach $900mn by 2024: Fractovia.org Fuel Cell Market size worth $25.5bn by 2024
Key Insights of Protein A Resins Market: • Global Market Insights, Inc. says Protein A Resin Market size is slated to surpass USD 900 million by 2024. • Protein A resin market is witnessing an inflection point with the increasing research on biotechnological sector for novel drug development. Growing prevalence of chronic diseases like rheumatoid arthritis, cancer, etc., and the extensive use of monoclonal antibodies in these treatments, is growing at an appreciable pace. • In addition to this, recent revolution in protein separation and purification techniques which include chromatography, precipitation, and filtration, is also expected to drive Protein A resin industry globally. • Protein A resin industry mainly finds its application in two areas- antibody purification, and immunoprecipitation. • Protein A resin market size in antibody purification is slated to witness a substantial growth in future, with an expected revenue share of USD 700 million by 2024, driven by the increasing diagnostic application of recombinant and monoclonal antibodies.
Continued… • Based on the product trends, recombinant Protein A resin market is forecast to outsell natural Protein A resin industry with a projected annual growth rate of 8.3% of the former over 2016-2024. • Geographically, U.S. Protein A resin industry covered 85% of the total share in 2015 and is expected to continue its regional dominance due to the dynamically increasing healthcare infrastructure related to clinical practices. • Asia Pacific market is also anticipated to show a striking annual growth rate of 8.5% over the coming seven years with a major contribution of Japan as it accounted for almost 40% of the total share in 2015, Japan protein A resin industry will exceed a revenue worth 78 million by 2024. • Biopharmaceutical industries accounted for a share of 75% of Protein A resin market in 2015, and is expected to surpass USD 680 million by 2024. • Prominent industry players include GE Healthcare, GenScript, Repligen, and Merck Millipore (EMD Millipore).
Japan Protein A Resin Market size, by matrix type, 2012-2024 (USD Million)
Browse Full Market Research Report Protein A Resins Market @ http://bit.ly/2oYMlcZ Request for a Sample of this Research report @ https://www.fractovia.org/request-sample/329
Table of Contents: Chapter 1. Methodology and Scope 1.1. Research Methodology 1.1.1. Initial data exploration 1.1.2. Statistical model and forecast 1.1.3. Industry insights and validation 1.1.4. Research scope and assumptions 1.2. Data Sources 1.2.1. Primary sources 1.2.2. Secondary sources Chapter 2. Executive Summary 2.1. Protein A Resin industry 3600 synopsis, 2012 - 2024 (USD Million) 2.1.1. Business trends 2.1.2. Matrix trends 2.1.3. Regional trends Chapter 3. Protein A Resin Industry Insights 3.1. Industry segmentation 3.2. Industry size and forecast, 2012 - 2024 3.3. Industry impact forces 3.3.1. Growth drivers 3.3.1.1. Increasing demand for therapeutic antibodies
Continued… 3.3.1.2. Increase in use of chromatography techniques for food additives 3.3.1.3. Drugs discovery and other research and development around the globe 3.3.2. Industry pitfalls & challenges 3.3.2.1. High cost associated with Protein A Resins 3.4. Growth potential analysis 3.4.1. New business models 3.5. Porter's analysis 3.6. Regulatory landscape 3.6.1. U.S. 3.6.2. Europe 3.6.3. China 3.7. Technology landscape 3.8. PESTEL analysis 3.9. Industry ecosystem analysis 3.10. Company market share analysis, 2015
Stay In Touch Website: https://www.fractovia.org Social Media: